Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 449
115th Congress(2017-2018)
Synthetic Drug Awareness Act of 2018
Active
Active
Passed House on Jun 12, 2018
Overview
Text
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 449 (Introduced-in-House)


115th CONGRESS
1st Session
H. R. 449


To require the Surgeon General of the Public Health Service to submit to Congress a report on the effects on public health of the increased rate of use of synthetic drugs.

IN THE HOUSE OF REPRESENTATIVES

January 11, 2017

Mr. Jeffries (for himself, Mr. Meehan, Mr. Gowdy, Mr. Collins of New York, and Mr. Butterfield) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To require the Surgeon General of the Public Health Service to submit to Congress a report on the effects on public health of the increased rate of use of synthetic drugs.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Synthetic Drug Awareness Act of 2017”.

SEC. 2. Report on effects on public health of synthetic drug use.

(a) In general.—Not later than three years after the date of the enactment of this Act, the Surgeon General of the Public Health Service shall submit to Congress a report on the effects on public health of the increase since January 2010 in the rate of use of synthetic drugs in the United States by individuals who are at least 12 years of age but not more than 18 years of age.

(b) Synthetic drug defined.—For purposes of subsection (a), the term “synthetic drug” means a drug which is developed and manufactured to avoid control under the Controlled Substances Act (21 U.S.C. 801 et seq.).